Lin Xie
Impact in
-
- Neurogenesis and neuroplasticity mechanisms
-
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 2
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Fei Xue (2 shared papers)Cheng Zhang (2 shared papers)Wenhai Sui (2 shared papers)Yun Zhang (2 shared papers)Jiahao Liu (1 shared paper)Yunjuan Sun (1 shared paper)David A. Greenberg (1 shared paper)Ming‐Liang He (1 shared paper)
In The Last Decade
Lin Xie
22 papers receiving 295 citations
Peers
Comparison fields: 5 of 69
- Developmental Neuroscience 16
- Cancer Research 36
- Genetics 18
- Cardiology and Cardiovascular Medicine 36
- Obstetrics and Gynecology 11
Countries citing papers authored by Lin Xie
This map shows the geographic impact of Lin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xie more than expected).
Fields of papers citing papers by Lin Xie
This network shows the impact of papers produced by Lin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xie. The network helps show where Lin Xie may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 59 | |
| 2 | 2023 | 32 | |
| 3 | 2022 | 28 | |
| 4 | 2002 | 28 | |
| 5 | 2022 | 23 | |
| 6 | 2023 | 22 | |
| 7 | 2024 | 21 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 19 | |
| 10 | 2022 | 10 | |
| 11 | 2025 | 7 | |
| 12 | 2020 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 3 | |
| 17 | LncRNA TEX41 regulates autophagy by increasing Runx2 expression in lung adenocarcinoma bone metastasis. | 2023 | 3 |
| 18 | 2025 | 2 | |
| 19 | 2025 | 1 | |
| 20 | [Homocysteine induces glomerular podocyte apoptosis via up-regulation of miR-488-3p expression in MPC-5 mice]. | 2022 | 1 |
About Lin Xie
Lin Xie is a scholar working on Molecular Biology, Oncology, Cancer Research, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology, having authored 24 papers that have together received 298 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Pregnancy and preeclampsia studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers), Peptidase Inhibition and Analysis (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers) and Birth, Development, and Health (2 papers). The work is most often cited by research in Developmental Neuroscience (16 citations), Cancer Research (36 citations), Genetics (18 citations), Cardiology and Cardiovascular Medicine (36 citations) and Obstetrics and Gynecology (11 citations). Lin Xie has collaborated with scholars based in China, Japan and Thailand. Frequent co-authors include Fei Xue, Cheng Zhang, Wenhai Sui, Yun Zhang, Jiahao Liu, Yunjuan Sun, David A. Greenberg, Ming‐Liang He, Bohong Zhang and Kunlin Jin. Their work appears in journals such as Acta Biochimica et Biophysica Sinica, Signal Transduction and Targeted Therapy, International Journal of Environmental Research and Public Health, Molecular Therapy and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.